Evaluation of the central effects of yangambin isolated from Ocotea duckei Vattimo: Behavioral and neurochemical study in mice motor cortex and striatum / Avaliação dos efeitos centrais da iangambina isolada de Ocotea duckei Vattimo: Estudo comportamental e neuroquímico em córtex motor e corpo estriado de camundongo

AUTOR(ES)
DATA DE PUBLICAÇÃO

2005

RESUMO

The effects of the acute administration of yangambin (25, 50 and 75 mg/kg intraperitoneal and oral), were studied in some animals behavioral models (open field, rotarod, forced swimming test, barbiturate-induced sleeping time, hole board, elevated plus maze, pentilenotetrazole-induced convulsion). Binding in vitro with differents concentrations of yangambin (0.5-200 microlitre), had been carried out to evaluate its interaction with the dopaminergic receptors (D1- and D2-like), muscarinic receptors (M1+M2)-like and serotonergic receptors (5-HT2)-like, as well as, HPLC studies to determine the effects of yangambin (25, 50 e 75 mg/kg, i.p.) after 24 h of its acute administration on the monoamines levels and its metabolites in mice motor cortex and striatum. The results showed that yangambin induced a significant reduction in the locomotor activity and the frequencies of rearing and grooming in the open field test, indicative of possible ansiolytic-like effect. These results can have related with the dopaminergic system, since that it had interaction of the yangambin with D1- e D2-símile receptors, in striatum and D2-símile in motor cortex, followed by a dopamine reduction, indicating a probable dopaminergic antagonistic action. The yangambin did not cause alteration in the motor coordination of the animals in the rotarod test, suggesting that the reduction of the locomotor activity can involve central action. It had a significant increase in the immobility of the mice in the forced swimming test induced by the yangambin. This effect, taken together with the reduction of the dopamine, noradrenaline and serotonin induced by yangambin in striatum, can explain its depressant effect in this model. Moreover, corroborating these results, the yangambin increased pentobarbital-induced sleeping time in treated mice, suggestive of central depressant effect. Yangambin in the doses used in this work, did not protect the animals from pentilenotetrazole-induced convulsions, suggesting that this effect depends on the used dose. In the hole board test, the yangambin increased the number of the head dips, in all the doses studied, intraperitoneal or oral, demonstrating ansiolytic activity. The ansiolytic effect of yangambin (75 mg/kg, i.p. and 25, 50 and 75 mg/kg, p.o.) was also confirmed in the elevated plus maze, where it presented significant increase in the percentage of the entries number in the open arms and the percentage of the time of permanence in the open arms. Yangambin 50 and 75 mg/kg, p.o., also increased the number of entries and the time of permanence in the open arms, respectively. However, yangambin 25 and 50 mg/kg, i.p., presented ansiogenic effect evidenced by the reduction of the time of permanence in the open arms which probably due to the absence of the formation of some active metabolite generated in the first-pass metabolism. The ansiolytic effect induced for yangambin 75 mg/kg, p.o., in the plus maze, was reverted with flumazenil (2.5 mg/kg, i.p.), indicating the possible participation of the GABAergic receptors in its mechanism of action. The ansiolytic effect of the yangambin, observed in the hole board and the plus maze test, was followed by a reduction of noradrenaline and serotonin in striatum, however, in the motor cortex, yangambin (75 mg/kg, i.p.), induced an increase of the noradrenaline levels, as well as yangambin (25, 50 and 75 mg/kg, i.p.) induced serotonin increase, demonstrating that the ansiolytic effect associated to the reduction of noradrenaline and serotonin depends on the cerebral area. The blockade of the dopaminergic receptors induced by yangambin was synergic to its agonist action on the cholinergic receptors, since that it did not modify the reduction of the locomotive activity of the animals in the open field test. The present work shows an interaction between the systems dopaminergic, cholinergic, serotonergic and GABAergic, that suggest the importance of yangambin in illnesses that modify these systems of neurotransmission. The yangambin presented compatible behavioural and neurochemical alterations with ansiolytic-like effect.

ASSUNTO(S)

lauraceae lignanas receptors, dopamine receptors, serotonin modelos animais ansiolíticos farmacologia epiyangambin farmacologia monoaminas biogênicas receptores dopaminergicos modelos animais lauraceae yangambin biogenic monoamines farmacologia ocotea receptores de serotonina pharmacology lauraceae receptors, muscarinic models, animal receptores muscarínicos receptores de serotonina anti-anxiety agents yangambin ansiolíticos monoaminas biogênicas lignans ocotea lignanas receptores muscarínicos ocotea receptores dopaminérgicos

ACESSO AO ARTIGO

Documentos Relacionados